ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. (NDRA) Revenue
Annual & quarterly revenue history · segment & region breakdown
NDRA · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsENDRA Life Sciences Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2014 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | -$0.00B | -100.00% |
| 2018-12-31 | $0.00B | -$0.00B | -98.24% |
| 2017-12-31 | $0.00B | -$0.00B | -31.80% |
| 2016-12-31 | $0.00B | -$0.00B | -63.44% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income ENDRA Life Sciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
ENDRA Life Sciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from ENDRA Life Sciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NDRA revenue · 4 questionsNDRA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · ENDRA Life Sciences Inc. SEC filings · GAAP · ENDRA Life Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026